Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against <i>Borrelia burgdorferi</i> In Vitro and In Vivo
Lyme disease caused by the <i>Borrelia burgdorferi</i> (<i>Bb or B. burgdorferi</i>) is the most common vector-borne, multi-systemic disease in the USA. Although most Lyme disease patients can be cured with a course of the first line of antibiotic treatment, some patients are...
Saved in:
Main Authors: | Hari-Hara S. K. Potula (Author), Jahanbanoo Shahryari (Author), Mohammed Inayathullah (Author), Andrey Victorovich Malkovskiy (Author), Kwang-Min Kim (Author), Jayakumar Rajadas (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
by: Kenneth B. Liegner
Published: (2019) -
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
by: Pothineni VR, et al.
Published: (2016) -
Monoinfections caused by Borrelia burgdorferi and Borrelia burgdorferi / Anaplasma phagocytophilum co-infections in forestry workers and farmers
by: Małgorzata Tokarska-Rodak, et al.
Published: (2015) -
Evaluation of Disulfiram Drug Combinations and Identification of Other More Effective Combinations against Stationary Phase <em>Borrelia burgdorferi</em>
by: Hector S. Alvarez-Manzo, et al.
Published: (2020) -
Effect of Invasion of <i>Borrelia burgdorferi</i> in Normal and Neoplastic Mammary Epithelial Cells
by: Gauri Gaur, et al.
Published: (2021)